ELECTRA PRESCRIBING SERVICES LTD

Active Ilford

Other human health activities

8 employees website.com
Other human health activities
E

ELECTRA PRESCRIBING SERVICES LTD

Other human health activities

Founded 18 Jul 2019 Active Ilford, England 8 employees website.com
Other human health activities
Accounts Submitted 22 Apr 2026 Next due 30 Apr 2026 22 days overdue
Confirmation Submitted 7 Aug 2025 Next due 22 Jul 2026 2 months remaining
Net assets £1M £203K 2025 year on year
Total assets £2M £190K 2025 year on year
Total Liabilities £581K £13K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

20 Frank Slater House Green Lane Ilford IG3 9RS England

Full company profile for ELECTRA PRESCRIBING SERVICES LTD (12111397), an active company based in Ilford, England. Incorporated 18 Jul 2019. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2020–2025)

Cash in Bank

£541.68k

Increased by £312.60k (+136%)

Net Assets

£1.08M

Increased by £203.11k (+23%)

Total Liabilities

£580.52k

Decreased by £12.72k (-2%)

Turnover

N/A

Employees

8

Debt Ratio

35%

Decreased by 5 (-13%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 136 Shares £136 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
10 Apr 2020136£136£1

Officers

Officers

2 active 1 resigned
Status
Ujjal SarkarDirectorBritishUnited Kingdom4618 Jul 2019Active
Vardalia, Arif ElyasDirectorBritishUnited Kingdom3910 May 2020Active

Shareholders

Shareholders (3)

Suvraneil Datta
50.0%
Sarit Ghosh
25.0%

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 Apr 2026AccountsAnnual accounts made up to 31 Jul 2025
7 Aug 2025Confirmation StatementConfirmation statement made on 8 Jul 2025 with no updates
29 Apr 2025AccountsAnnual accounts made up to 31 Jul 2024
22 Jul 2024Confirmation StatementConfirmation statement made on 8 Jul 2024 with no updates
26 Mar 2024AccountsAnnual accounts made up to 31 Jul 2023
22 Apr 2026 Accounts

Annual accounts made up to 31 Jul 2025

7 Aug 2025 Confirmation Statement

Confirmation statement made on 8 Jul 2025 with no updates

29 Apr 2025 Accounts

Annual accounts made up to 31 Jul 2024

22 Jul 2024 Confirmation Statement

Confirmation statement made on 8 Jul 2024 with no updates

26 Mar 2024 Accounts

Annual accounts made up to 31 Jul 2023

Recent Activity

Latest Activity

Annual accounts made up to 31 Jul 2025

4 weeks ago on 22 Apr 2026

Confirmation statement made on 8 Jul 2025 with no updates

9 months ago on 7 Aug 2025

Annual accounts made up to 31 Jul 2024

1 years ago on 29 Apr 2025

Confirmation statement made on 8 Jul 2024 with no updates

1 years ago on 22 Jul 2024

Annual accounts made up to 31 Jul 2023

2 years ago on 26 Mar 2024